The Bestselling Drug Products of 2023: Ranking All 152 Blockbusters

Solt DB combed over dozens of financial filings from multiple countries to build the most comprehensive dataset of global blockbuster drugs.
By
Maxx Chatsko
Updated
August 18, 2024
Published
June 19, 2024

Learn Additional Business Context

An icon graphic of a mouse cursor.
Back to Data Visualizations
Members have access to additional investing context for the topic above.
Member Benefits
Pricing

This topic was discussed in an article:

World's Bestselling Drugs Addicted to Broken U.S. Healthcare System

February 4, 2026
The global drug development industry boasted 152 blockbuster drugs that generated combined revenue of $511 billion in 2023. Over 58% percent ($298 billion) was generated from patients in the United States.
Learn More

This topic can be explored through this external primary source:

Learn More

This topic can be explored through this external primary source:

Learn More

This topic can be explored through this external primary source:

Learn More
ABOUT
What Is Solt DB?
Public Benefit
Our Lonely Team
PUBLIC CONTENT
Articles
Data Visualizations
Newsletter
INVESTING
Pricing
Member Benefits
Stocks We Cover
CONTACT
Questions?
Critiques?
Love letters?

Reach out here.
About Solt DB

Solt DB is an equities research firm and public benefit company exploring the business of biotech. For scientists, investors, and nerds of all stripes -- or feathers.

Yinz respect the finch n@. 2026 Solt DB.
A white logo of LinkedIn.